NCT00626002

Brief Summary

The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
2,301

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Feb 2008

Typical duration for phase_3

Geographic Reach
14 countries

152 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

February 22, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 29, 2008

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

January 30, 2013

Status Verified

January 1, 2013

Enrollment Period

3.7 years

First QC Date

February 22, 2008

Last Update Submit

January 28, 2013

Conditions

Keywords

Open label

Outcome Measures

Primary Outcomes (4)

  • Proportion of subjects achieving PGA "clear" (0) or "minimal" (1) scores by visit.

    Visit (12 weeks)

  • Proportion of subjects achieving a > PASI 50 clinical response that is defined as a reduction on PASI scores by at least 50% relative to Baseline, by visit.

    Visit (12 weeks)

  • Proportion of subjects achieving a > PASI 75 clinical response that is defined as a reduction on PASI scores by at least 50% relative to Baseline, by visit.

    Visit (12 weeks)

  • AEs, serious adverse events (SAEs), laboratory data, ADA and vital signs will be assessed throughout the study

    Visit (12 weeks)

Study Arms (1)

1

EXPERIMENTAL
Drug: ABT-874

Interventions

100mg ABT-874 administered SQ every 4 wks for approximately 204 weeks

Also known as: briakinumab
1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having participated in a preceding ABT-874 clinical trial for ABT-874
  • Subject has a clinical diagnosis of moderate to severe plaque psoriasis

You may not qualify if:

  • Subjects who prematurely discontinued in any preceding psoriasis study with ABT-874 other than protocol-required discontinuation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (152)

Site Reference ID/Investigator# 7496

Birmingham, Alabama, 35205, United States

Location

Site Reference ID/Investigator# 8438

Birmingham, Alabama, 35233, United States

Location

Site Reference ID/Investigator# 7522

Huntsville, Alabama, 35801, United States

Location

Site Reference ID/Investigator# 7774

Scottsdale, Arizona, 85251, United States

Location

Site Reference ID/Investigator# 7435

Tucson, Arizona, 85710, United States

Location

Site Reference ID/Investigator# 7933

Little Rock, Arkansas, 72204, United States

Location

Site Reference ID/Investigator# 7234

Bakersfield, California, 93309, United States

Location

Site Reference ID/Investigator# 8249

Fresno, California, 93720, United States

Location

Site Reference ID/Investigator# 7332

Irvine, California, 92697, United States

Location

Site Reference ID/Investigator# 7239

Los Angeles, California, 90045, United States

Location

Site Reference ID/Investigator# 8390

Oceanside, California, 92056, United States

Location

Site Reference ID/Investigator# 7503

San Diego, California, 92103, United States

Location

Site Reference ID/Investigator# 7520

San Diego, California, 92117, United States

Location

Site Reference ID/Investigator# 7010

San Diego, California, 92123, United States

Location

Site Reference ID/Investigator# 10962

San Francisco, California, 94118, United States

Location

Site Reference ID/Investigator# 7334

Santa Monica, California, 90404, United States

Location

Site Reference ID/Investigator# 7793

Vallejo, California, 94589, United States

Location

Site Reference ID/Investigator# 7929

Denver, Colorado, 80209, United States

Location

Site Reference ID/Investigator# 7436

Longmont, Colorado, 80501, United States

Location

Site Reference ID/Investigator# 7521

New Haven, Connecticut, 06511, United States

Location

Site Reference ID/Investigator# 7653

Doral, Florida, 33166-6665, United States

Location

Site Reference ID/Investigator# 8341

Jacksonville, Florida, 32204, United States

Location

Site Reference ID/Investigator# 7716

Miami, Florida, 33136, United States

Location

Site Reference ID/Investigator# 7657

Miami, Florida, 33144, United States

Location

Site Reference ID/Investigator# 10841

South Miami, Florida, 33143, United States

Location

Site Reference ID/Investigator# 7893

West Palm Beach, Florida, 33409-3509, United States

Location

Site Reference ID/Investigator# 7331

Alpharetta, Georgia, 30022, United States

Location

Site Reference ID/Investigator# 9743

Atlanta, Georgia, 30327, United States

Location

Site Reference ID/Investigator# 7891

Newnan, Georgia, 30263, United States

Location

Site Reference ID/Investigator# 7932

Snellville, Georgia, 30078, United States

Location

Site Reference ID/Investigator# 8379

Arlington Heights, Illinois, 60005, United States

Location

Site Reference ID/Investigator# 8798

Maywood, Illinois, 60153, United States

Location

Site Reference ID/Investigator# 10703

Schaumburg, Illinois, 60194, United States

Location

Site Reference ID/Investigator# 6950

Skokie, Illinois, 60077, United States

Location

Site Reference ID/Investigator# 7892

West Dundee, Illinois, 60118, United States

Location

Site Reference ID/Investigator# 6933

Indianapolis, Indiana, 46256, United States

Location

Site Reference ID/Investigator# 10422

Indianapolis, Indiana, 46260, United States

Location

Site Reference ID/Investigator# 16581

Plainfield, Indiana, 46168, United States

Location

Site Reference ID/Investigator# 7992

Overland Park, Kansas, 66202, United States

Location

Site Reference ID/Investigator# 17193

Henderson, Kentucky, 42420, United States

Location

Site Reference ID/Investigator# 8528

Louisville, Kentucky, 40202, United States

Location

Site Reference ID/Investigator# 9962

Owensboro, Kentucky, 42303, United States

Location

Site Reference ID/Investigator# 8529

Andover, Massachusetts, 01810, United States

Location

Site Reference ID/Investigator# 8149

Boston, Massachusetts, 02111, United States

Location

Site Reference ID/Investigator# 9823

Detroit, Michigan, 48202, United States

Location

Site Reference ID/Investigator# 7883

Fort Gratiot, Michigan, 48059, United States

Location

Site Reference ID/Investigator# 7238

Grand Blanc, Michigan, 48439, United States

Location

Site Reference ID/Investigator# 7656

Fridley, Minnesota, 55432, United States

Location

Site Reference ID/Investigator# 6930

St Louis, Missouri, 63110, United States

Location

Site Reference ID/Investigator# 6949

St Louis, Missouri, 63117, United States

Location

Site Reference ID/Investigator# 7240

Omaha, Nebraska, 68131, United States

Location

Site Reference ID/Investigator# 9567

Omaha, Nebraska, 68144, United States

Location

Site Reference ID/Investigator# 7757

Berlin, New Jersey, 08009, United States

Location

Site Reference ID/Investigator# 7330

East Windsor, New Jersey, 08520, United States

Location

Site Reference ID/Investigator# 7882

New Brunswick, New Jersey, 08903, United States

Location

Site Reference ID/Investigator# 7455

Albuquerque, New Mexico, 87106, United States

Location

Site Reference ID/Investigator# 8078

Buffalo, New York, 14221, United States

Location

Site Reference ID/Investigator# 8392

New York, New York, 10016, United States

Location

Site Reference ID/Investigator# 8006

New York, New York, 10025, United States

Location

Site Reference ID/Investigator# 7230

New York, New York, 10029-6501, United States

Location

Site Reference ID/Investigator# 10201

New York, New York, 10032, United States

Location

Site Reference ID/Investigator# 8037

Rochester, New York, 14623, United States

Location

Site Reference ID/Investigator# 7333

Stoney Brook, New York, 11790, United States

Location

Site Reference ID/Investigator# 7434

Hickory, North Carolina, 28602, United States

Location

Site Reference ID/Investigator# 8117

Wilmington, North Carolina, 28401, United States

Location

Site Reference ID/Investigator# 9681

Winston-Salem, North Carolina, 27157, United States

Location

Site Reference ID/Investigator# 6945

Cincinnati, Ohio, 45219, United States

Location

Site Reference ID/Investigator# 23345

Cincinnati, Ohio, 45220, United States

Location

Site Reference ID/Investigator# 7044

Cleveland, Ohio, 44106, United States

Location

Site Reference ID/Investigator# 7899

Columbus, Ohio, 43212, United States

Location

Site Reference ID/Investigator# 8389

Dayton, Ohio, 45408, United States

Location

Site Reference ID/Investigator# 11181

Oklahoma City, Oklahoma, 73104, United States

Location

Site Reference ID/Investigator# 6936

Lake Oswego, Oregon, 97035, United States

Location

Site Reference ID/Investigator# 7703

Portland, Oregon, 97210, United States

Location

Site Reference ID/Investigator# 6948

Portland, Oregon, 97223, United States

Location

Site Reference ID/Investigator# 11424

Portland, Oregon, 97239, United States

Location

Site Reference ID/Investigator# 8494

Hershey, Pennsylvania, 17033, United States

Location

Site Reference ID/Investigator# 7930

Philadelphia, Pennsylvania, 19103, United States

Location

Site Reference ID/Investigator# 6934

Johnston, Rhode Island, 02919, United States

Location

Site Reference ID/Investigator# 6935

Providence, Rhode Island, 02903, United States

Location

Site Reference ID/Investigator# 7785

Greer, South Carolina, 29650, United States

Location

Site Reference ID/Investigator# 7497

Goodlettsville, Tennessee, 37072, United States

Location

Site Reference ID/Investigator# 7388

Knoxville, Tennessee, 37934, United States

Location

Site Reference ID/Investigator# 6931

Nashville, Tennessee, 37215, United States

Location

Site Reference ID/Investigator# 7684

Arlington, Texas, 76011, United States

Location

Site Reference ID/Investigator# 10842

Austin, Texas, 78759, United States

Location

Site Reference ID/Investigator# 7498

Dallas, Texas, 75230, United States

Location

Site Reference ID/Investigator# 6947

Dallas, Texas, 75246-1613, United States

Location

Site Reference ID/Investigator# 6944

Houston, Texas, 77030, United States

Location

Site Reference ID/Investigator# 7758

San Antonio, Texas, 78229, United States

Location

Site Reference ID/Investigator# 8108

San Antonio, Texas, 78229, United States

Location

Site Reference ID/Investigator# 6937

Tyler, Texas, 75703, United States

Location

Site Reference ID/Investigator# 7655

Webster, Texas, 77598, United States

Location

Site Reference ID/Investigator# 10207

Salt Lake City, Utah, 84132, United States

Location

Site Reference ID/Investigator# 6946

Norfolk, Virginia, 23507, United States

Location

Site Reference ID/Investigator# 6932

Seattle, Washington, 98101, United States

Location

Site Reference ID/Investigator# 10306

Spokane, Washington, 99204, United States

Location

Site Reference ID/Investigator# 7884

Milwaukee, Wisconsin, 53209, United States

Location

Site Reference ID/Investigator# 16845

Graz, 8036, Austria

Location

Site Reference ID/Investigator# 18183

Vienna, 1090, Austria

Location

Site Reference ID/Investigator# 15761

Brussels, 1200, Belgium

Location

Site Reference ID/Investigator# 7991

Barrie, L4M 6L2, Canada

Location

Site Reference ID/Investigator# 8047

Calgary, T3G 0B4, Canada

Location

Site Reference ID/Investigator# 7996

Edmonton, T5K 1X3, Canada

Location

Site Reference ID/Investigator# 6996

Halifax, B3H 0A2, Canada

Location

Site Reference ID/Investigator# 7236

Hamilton, L8N 1V6, Canada

Location

Site Reference ID/Investigator# 6995

Laval, H7S 2C6, Canada

Location

Site Reference ID/Investigator# 6998

London, N5X 2P1, Canada

Location

Site Reference ID/Investigator# 7043

London, N6A 3H7, Canada

Location

Site Reference ID/Investigator# 7329

Markham, L3P 1A8, Canada

Location

Site Reference ID/Investigator# 6999

Montreal, H2K 4L5, Canada

Location

Site Reference ID/Investigator# 7652

Montreal, H3H 1V4, Canada

Location

Site Reference ID/Investigator# 7006

North Bay, P1B 3Z7, Canada

Location

Site Reference ID/Investigator# 8102

Ottawa, K2G 6E2, Canada

Location

Site Reference ID/Investigator# 6993

Québec, G1V 4X7, Canada

Location

Site Reference ID/Investigator# 8112

St. John's, A1A 5E8, Canada

Location

Site Reference ID/Investigator# 7931

Surrey, V3R 6A7, Canada

Location

Site Reference ID/Investigator# 8118

Vancouver, V5Z 3Y1, Canada

Location

Site Reference ID/Investigator# 6997

Vancouver, V5Z 4E8, Canada

Location

Site Reference ID/Investigator# 6994

Waterloo, N2J 1C4, Canada

Location

Site Reference ID/Investigator# 8111

Westmount, H3Z 2S6, Canada

Location

Site Reference ID/Investigator# 7005

Windsor, N8W 1E6, Canada

Location

Site Reference ID/Investigator# 7979

Windsor, N8W 5L7, Canada

Location

Site Reference ID/Investigator# 8348

Winnipeg, R3C 1R4, Canada

Location

Site Reference ID/Investigator# 17781

Aarhus, 8000, Denmark

Location

Site Reference ID/Investigator# 18041

Copenhagen NV, 2400, Denmark

Location

Site Reference ID/Investigator# 18661

Helsinki, 00029 HUS, Finland

Location

Site Reference ID/Investigator# 18701

Kuopio, 70210, Finland

Location

Site Reference ID/Investigator# 14962

Lahti, 15850, Finland

Location

Site Reference ID/Investigator# 19241

Turku, 20521, Finland

Location

Site Reference ID/Investigator# 18502

Nice, 06200, France

Location

Site Reference ID/Investigator# 16781

Paris, 75475, France

Location

Site Reference ID/Investigator# 18506

Toulouse, 31059, France

Location

Site Reference ID/Investigator# 16281

Berlin, 10117, Germany

Location

Site Reference ID/Investigator# 15664

Frankfurt am Main, 60590, Germany

Location

Site Reference ID/Investigator# 15663

Hamburg, D-20354, Germany

Location

Site Reference ID/Investigator# 16381

Kiel, 24105, Germany

Location

Site Reference ID/Investigator# 16143

Munich, D-80337, Germany

Location

Site Reference ID/Investigator# 16161

Münster, 48149, Germany

Location

Site Reference ID/Investigator# 17676

Tübingen, 72076, Germany

Location

Site Reference ID/Investigator# 16282

Athens, 161 21, Greece

Location

Site Reference ID/Investigator# 15921

Athens, 16121, Greece

Location

Site Reference ID/Investigator# 15922

Thessaloniki, 54643, Greece

Location

Site Reference ID/Investigator# 15401

Modena, 41100, Italy

Location

Site Reference ID/Investigator# 14881

Rome, 00133, Italy

Location

Site Reference ID/Investigator# 19322

Barcelona, 08916, Spain

Location

Site Reference ID/Investigator# 15341

Madrid, 28006, Spain

Location

Site Reference ID/Investigator# 16142

Stockholm, 171 76, Sweden

Location

Site Reference ID/Investigator# 17721

Geneva, 1211, Switzerland

Location

Site Reference ID/Investigator# 16749

Zurich, 8091, Switzerland

Location

Site Reference ID/Investigator# 19045

Aberdeen, AB25 2ZR, United Kingdom

Location

Site Reference ID/Investigator# 15422

Manchester, M6 8HD, United Kingdom

Location

MeSH Terms

Interventions

briakinumab

Study Officials

  • Martin Kaul, MD

    AbbVie

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2008

First Posted

February 29, 2008

Study Start

February 1, 2008

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

January 30, 2013

Record last verified: 2013-01

Locations